↓ Skip to main content

Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain

Overview of attention for article published in BMC Infectious Diseases, April 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of posaconazole versusfluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain
Published in
BMC Infectious Diseases, April 2012
DOI 10.1186/1471-2334-12-83
Pubmed ID
Authors

Santiago Grau, Rafael de la Cámara, Francisco J Sabater, Isidro Jarque, Enric Carreras, Miguel A Casado, Miguel A Sanz

Abstract

We evaluated the cost-effectiveness of posaconazole compared with standard azole therapy (SAT; fluconazole or itraconazole) for the prevention of invasive fungal infections (IFI) and the reduction of overall mortality in high-risk neutropenic patients with acute myelogenous leukaemia (AML) or myelodysplastic syndromes (MDS). The perspective was that of the Spanish National Health Service (NHS).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Spain 1 2%
Italy 1 2%
Brazil 1 2%
Unknown 46 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 22%
Other 8 16%
Student > Master 7 14%
Student > Ph. D. Student 4 8%
Lecturer > Senior Lecturer 4 8%
Other 12 24%
Unknown 4 8%
Readers by discipline Count As %
Medicine and Dentistry 25 50%
Nursing and Health Professions 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Biochemistry, Genetics and Molecular Biology 2 4%
Agricultural and Biological Sciences 2 4%
Other 3 6%
Unknown 11 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2012.
All research outputs
#17,656,152
of 22,664,267 outputs
Outputs from BMC Infectious Diseases
#5,064
of 7,636 outputs
Outputs of similar age
#120,274
of 161,135 outputs
Outputs of similar age from BMC Infectious Diseases
#67
of 95 outputs
Altmetric has tracked 22,664,267 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,135 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.